About
Welcome to our website
NephSol, Inc., based in Tuscaloosa, Alabama, is an innovative startup focused on enhancing the safety and effectiveness of dialysis treatments. Co-founded by Olivia Bruno and Sydney Ringold, both graduates of the University of Alabama, the company is developing a cutting-edge device that monitors cerebral blood flow during dialysis. This technology is designed to mitigate the risks associated with decreased blood flow to the brain, which can lead to severe side effects or even increase mortality rates among dialysis patients.
Recently, NephSol gained significant recognition by winning $25,000 in the concept stage of the Alabama Launchpad Cycle 2 competition in 2024. This victory not only provides them with the necessary funds to move forward with regulatory filings but also positions them to potentially bring their device to market in the near future. This accomplishment highlights the importance of their work in addressing critical health challenges within the dialysis community (Business Alabama Magazine).